DGIdb - GLUTAMINE Drug Record

GLUTAMINE chembl:CHEMBL930 Approved

Alternate Names:

L-GLUTAMINE
LEVOGLUTAMIDE
FEMA NO. 3684
ENDARI
GLUTAMINE
NSC-27421
NUTRESTORE
(2S)-2,5-DIAMINO-5-OXOPENTANOIC ACID
L-GLUTAMIC ACID GAMMA-AMIDE
L-(+)-GLUTAMINE
GLN
(2S)-2-AMINO-4-CARBAMOYLBUTANOIC ACID
L-GLUTAMIC ACID Γ-AMIDE
GLUTAMIC ACID 5-AMIDE
L-GLUTAMIN
L-GLUTAMINSAEURE-5-AMID
GLUTAMIC ACID AMIDE
(S)-2,5-DIAMINO-5-OXOPENTANOIC ACID
L-2-AMINOGLUTARAMIC ACID
L-GLUTAMINSÄURE-5-AMID
Q
chemidplus:56-85-9
rxcui:4885
drugbank:00130
chembl:CHEMBL930
pubchem.compound:5961

Drug Info:

(0 More Sources)

Publications:

Zhou et al., 2006, [The effect of glutamine on the growth, metabolism and endostatin production of microencapsulated rCHO cells]., Sheng Wu Gong Cheng Xue Bao
Todorova et al., 2006, Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine., Nutr Cancer
Wasa et al., 2002, Characterization of L-glutamine transport by a human neuroblastoma cell line., Am. J. Physiol., Cell Physiol.
Meng et al., 2004, Insulin-like growth factor-2 activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases., J. Gastrointest. Surg.
Squires et al., 1997, Regulation of hepatic glutaminase in the streptozotocin-induced diabetic rat., Diabetes
Noguchi et al., 1997, Increased glutamine consumption in small intestine epithelial cells during sepsis in rats., Am. J. Surg.
Smith et al., 1984, Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells., J. Cell. Physiol.
Castell et al., 2004, Granule localization of glutaminase in human neutrophils and the consequence of glutamine utilization for neutrophil activity., J. Biol. Chem.
Kovacević, 1975, Possible mechanisms of the efflux of glutamate from kidney mitochondria generated by the activity of mitochondrial glutaminase., Biochim. Biophys. Acta
Curthoys, 2001, Role of mitochondrial glutaminase in rat renal glutamine metabolism., J. Nutr.
Huang et al., 1999, Induction of gadd153 mRNA by nutrient deprivation is overcome by glutamine., Biochem. J.

GLUTAMINE SLC1A5

Interaction Score: 20.61

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
11997238

Sources:
NCI
GLUTAMINE COL18A1

Interaction Score: 2.58

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16572858

Sources:
NCI
GLUTAMINE IGF2

Interaction Score: 1.47

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
14746834

Sources:
NCI
GLUTAMINE GLS

Interaction Score: 1.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
9392478 9124626 6146632 14722097 1174515 11533299

Sources:
NCI
GLUTAMINE DDIT3

Interaction Score: 0.79

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10377266

Sources:
NCI
GLUTAMINE MYC

Interaction Score: 0.52

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16898871

Sources:
NCI

NCI: GLUTAMINE

Version: 14-September-2017

Alternate Names:

C522 NCI drug code

Drug Info:

Publications:

Noguchi et al., 1997, Increased glutamine consumption in small intestine epithelial cells during sepsis in rats., Am. J. Surg.

Smith et al., 1984, Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells., J. Cell. Physiol.

Squires et al., 1997, Regulation of hepatic glutaminase in the streptozotocin-induced diabetic rat., Diabetes

NCI: L-GLUTAMINE
- Version: 14-September-2017
Alternate Names:

C522 NCI drug code

Drug Info:

Publications:

Meng et al., 2004, Insulin-like growth factor-2 activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases., J. Gastrointest. Surg.
NCI: GLN
- Version: 14-September-2017
Alternate Names:

C522 NCI drug code

Drug Info:

Publications:

Todorova et al., 2006, Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine., Nutr Cancer
ChemblDrugs: chembl:CHEMBL930
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:

GLUTAMINE Drug Record

GLUTAMINE chembl:CHEMBL930 Approved

Alternate Names:

Drug Info:

Publications:

GLUTAMINE SLC1A5

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 11997238

Sources: NCI

GLUTAMINE COL18A1

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16572858

Sources: NCI

GLUTAMINE IGF2

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 14746834

Sources: NCI

GLUTAMINE GLS

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 9392478 9124626 6146632 14722097 1174515 11533299

Sources: NCI

GLUTAMINE DDIT3

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 10377266

Sources: NCI

GLUTAMINE MYC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 16898871

Sources: NCI

NCI: GLUTAMINE

Alternate Names: C522 NCI drug code

Drug Info:

NCI: L-GLUTAMINE

Alternate Names: C522 NCI drug code

Drug Info:

Publications: Meng et al., 2004, Insulin-like growth factor-2 activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases., J. Gastrointest. Surg.

NCI: GLN

Alternate Names: C522 NCI drug code

Drug Info:

Publications: Todorova et al., 2006, Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine., Nutr Cancer

ChemblDrugs: chembl:CHEMBL930

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
11997238

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
16572858

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
14746834

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
9392478 9124626 6146632 14722097 1174515 11533299

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
10377266

Sources:
NCI

Interaction Types & Directionality:

n/a

PMIDs:
16898871

Sources:
NCI

Alternate Names:

C522 NCI drug code

Alternate Names:

C522 NCI drug code

Publications:

Meng et al., 2004, Insulin-like growth factor-2 activation of intestinal glutamine transport is mediated by mitogen-activated protein kinases., J. Gastrointest. Surg.

Alternate Names:

C522 NCI drug code

Publications:

Todorova et al., 2006, Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine., Nutr Cancer